4 results
To confirm previous study results using a Solace Balloon and to support future marketing efforts in the European Union and provide data for publications.
Part I (cross-sectional study)1. To identify breathprints of VOCs by electronic nose in exhaled air that are associated with a bacterial origin of an exacerbation in COPD patients. 2. To examine the critical VOCs of these breathprints in exhaled air…
The primary objective of the study is to compare the progression-free survival (PFS) of REGN2810 (cemiplimab) plus ipilimumab combination therapy (hereinafter referred to as REGN2810/ipi) and REGN2810 plus 2 cycles only of platinum-based doublet…
PrimaryPhase 1-To characterize the safety and tolerability of isatuximab in combination with cemiplimab in participants with relapsed and refractory cHL, DLBCL or PTCL, and to confirm the recommended Phase 2 dose (RP2D).Phase 2- Cohort A1 (anti-…